N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial.
| Image |  |
|---|---|
| Description | scientific article published on 24 June 2013 |
| Author/s |
author: Amylou Dueck |
| Publication date | June 24, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |